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Background: Coronary artery bypass grafting (CABG) improves survival in patients with multivessel coronary artery disease. Bypass grafts 
with multiple distal targets (MDTs) require less graft material and reduce cardiopulmonary bypass time. Secondary analyses of clinical trials 
have reported higher major adverse cardiac events associated with MDT grafts, However, a contemporary real-world analysis reporting 
long term outcomes associated with MDT grafts is lacking.
methods: In the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) registry a total of 6,262 
consecutive patients who underwent an isolated first CABG between 2004 and 2012 were included. Median follow-up was 7 years. A 
propensity score was used to match CABG patients with and without MDTs and multivariable logistic regression was used to adjust for 
completeness of revascularization. Outcomes of interest included mortality at 30-days and 1 year. In the subgroup of 360 patients who 
underwent a follow-up angiogram during the study period, the incidence of graft failure in MDT and single distal target (SDT) grafts, defined 
as >70% stenosis, was described.
results: A total of 549 (8.8%) CABG patients had a MDT and were matched with 482 patients SDTs. Patients with MDTs were more likely 
to have diabetes, heart failure, renal failure, triple vessel disease, longer mean cardiopulmonary bypass times and more distal targets 
(mean of 4.75 vs 3.35, p< 0.001). No differences in mortality were observed at 30 days (2% vs 2.7%, adjusted OR [aOR] 0.74, 95% CI 
0.32-1.66) or 1-year (3.8% vs 4.3%, aOR 0.87, 95% CI 0.47-1.61, p= 0.67). The incidence of graft failure was numerically higher in MDTs 
grafts (37.8% vs 27.6%, p=0.18).
Conclusion:  In a large unselected cohort, no differences in mortality were observed between coronary bypass patients with MDTs and 
SDTs despite a numerically higher incidence of graft failure. Our findings suggest that CABG with SDTs are more durable; however these 
results also support the safety of MDTs to facilitate complete revascularization when graft material is limited.
